Navigation Links
Novel stroke treatment passes safety stage of UCI-led clinical trial
Date:3/10/2010

Irvine, Calif., March 10, 2010 A clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage, according to the UC Irvine neurologist who led the effort.

Dr. Steven C. Cramer said patients showed no ill effects after the sequential administration of growth factors encouraging the creation of neurons in stroke-damaged areas of the brain. All new drug treatments must pass this safety stage before doctors can study their effectiveness in subsequent studies.

Results of the phase IIa trial appear on the Web site of Stroke, a journal of the American Heart Association.

Within two days of suffering ischemic stroke, patients were put on a nine-day treatment course, starting with three once-daily injections of beta-hCG, a hormone that triggers the growth of neural stem cells. They then received three once-daily injections of erythropoietin, a hormone that directs these neural stem cells to become neurons.

Cramer, associate professor of neurology at UCI, said this combination of growth factors had been shown in animal studies to engender neuron creation leading to the recovery of a range of movement.

In the human safety study, he teamed with physicians from UC Irvine Medical Center; Hoag Memorial Hospital Presbyterian in Newport Beach, Calif.; and the University of Calgary in Canada. They administered the treatment to 15 patients. No safety concerns were noted, and a majority of treated patients had minimal or no disability after three months.

A phase IIb clinical trial is now under way to compare the stroke therapy with placebo.

The study is supported by Stem Cell Therapeutics a Canadian biotechnology company that conceived of an approach using this specific sequence of growth factors and the National Center for Research Resources.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Page: 1

Related medicine news :

1. Reovirus may be a novel approach to prostate cancer treatment
2. Novel program translates behavioral and social science research into treatments to reduce obesity
3. A novel in vitro model for light-induced wound healing
4. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
5. New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
6. Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts
7. A novel computational model -- how Parkinsons medications affect learning and attention
8. TD2 and Critical Outcome Technologies Inc. develop novel anti-cancer drug
9. New human reproductive hormone could lead to novel contraceptives
10. Researchers discover novel method for detecting MIRCERA
11. Novel detection method unmasks circulating breast cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... (PRWEB) May 03, 2015 Looking ... that will directly impact your career? The Master ... for dynamic leaders in multinational companies and for ... In a changing global landscape, differences in culture, ... relationships. The EMIB program develops the global competence ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company that ... the , May 5 - 7, 2015 Minnesota Safety ... the conference include its bestselling TaskMate sit stand solutions. ... 6100 TaskMate Executive. Features of the 6100 TaskMate Executive ... extended platform work surface and supply holders. Weighing 50 ...
(Date:5/2/2015)... 2015 “ ActOn ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... with organizations to make a difference. , In this material ... things that aren’t about money, which is why those things ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 “ Peachtree ... its monthly Tech Report, which features the latest and ... technology expert and special reporter for NewsWatch, conducted the ... high-end audio equipment. , Music is an important ... should be pampered and given the royal treatment. Peachtree ...
(Date:5/2/2015)... ZoomCare, the Portland-based innovator of on-demand healthcare announces ... new healthcare insurance to individuals and small businesses on ... is the nation’s first health insurance system built from ... Health Insurance was ZoomCare’s first such filing including rates ... review and regulation by the Oregon Insurance Division. Once ...
Breaking Medicine News(10 mins):Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:ZoomCare Applies to be on Oregon Exchange 2
... done on federal, state levels to combat tobacco use, ... Anti-tobacco campaigns registered some significant gains in 2007, with ... there,s still too little federal and state funding for ... their cigarette taxes. , That,s the conclusion of the ...
... David Schlotterbeck Named Vice Chairmen, DUBLIN, Ohio, Jan. ... services that improve the safety and,productivity of health care, ... of Teva North America, will join the company as,vice ... Supply Chain,Services sector., Barrett, 52, will join the ...
... With an eye to helping,customers improve their ... ) is now packing its Luxury and Ultra ... before., All Bragada Luxury mattresses will now ... the fabric. One of the softest fabrics,available for ...
... Her Battle ... with Hepatitis C, NEW YORK, Jan. ... advocating on behalf of,Americans with liver disease, is proud announce that it ... disease,including hepatitis C. To help spread the word about ALF,s work, EHE ...
... Compound Commonly Prescribed Hormone,Treatments, Use the Term "Bio-identical", ... a series of,warning letters to compounding pharmacies across ... asserted a policy that would deny hundreds of,thousands ... substituting its judgment for that of doctors. Wyeth,Pharmaceuticals, ...
... first Southern-style canned product ... American Heart Association, COLUMBUS, Ohio, Jan. 9 ... low fat and meatless, were the first,product line of ... savory,taste. Now, heart-healthy Sensibly Seasoned products also bear the ...
Cached Medicine News:Health News:Smoke-Free Workplace Laws, Cigarette Taxes on the Rise 2Health News:Smoke-Free Workplace Laws, Cigarette Taxes on the Rise 3Health News:Smoke-Free Workplace Laws, Cigarette Taxes on the Rise 4Health News:Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector 2Health News:Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector 3Health News:Bragada(R) Luxury Mattress, Inc. Upgrades Luxury and Ultra Luxury Collections 2Health News:EHE International Supports the American Liver Foundation's Efforts at Raising Awareness for Hepatitis 2Health News:FDA Asserts New Policy to Restrict Women's Access to Bioidentical Hormones 2Health News:Glory Foods Receives Heart Healthy Certification 2
(Date:5/1/2015)... N.J., May 1, 2015 Cambrex Corporation (NYSE: ... 31, 2015. Highlights , Sales ... increased 27% excluding foreign currency impact, driven by Innovator products ... from $8.4 million in the first quarter of 2014. ... $0.04 in the first quarter last year and Adjusted Diluted ...
(Date:4/30/2015)... , April 30, 2015  Accuray Incorporated ... has signed an agreement with MIM Software Inc. ... TomoTherapy ® and CyberKnife ® product portfolios. ... and MIM technology. This is Accuray,s second collaboration ... development of the first iPad-based treatment plan review ...
(Date:4/30/2015)... -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) announced today ... after the market closes on Thursday, May 7, 2015.  ... held on Thursday, May 7, 2015, at 4:30 p.m. ... participate in the call, please dial 877-303-1298 (for U.S. ... the teleconference will be available for one week and ...
Breaking Medicine Technology:Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2
... with its new stand F19 contains three high ... one hand to homogenously move the arms and ... solid and stable microscope. The Leica M844 F19 ... on the same small footprint and holds the ...
... is a high-throughput immunoassay system built around ... 2000 with the important addition of Logic ... to be designed for optimal performance with ... for critical assays such as the cardiac ...
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use....
Medicine Products: